SEOUL, South Korea, Dec. 26, 2025 /PRNewswire/ -- ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, announced that ABL Bio will receive a USD 40 million upfront payment for ...

SEOUL, South Korea, Dec. 25, 2025 /CNW/ -- ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, announced that ABL Bio will receive a USD 40 million upfront payment for the ...

UNIONDALE, NY - ProPhase Labs, Inc. (NASDAQ:PRPH) and European biotechnology group Advanced Biological Laboratories S.A. (ABL) announced Friday they have entered into a non-binding Letter of Intent ...

The contemplated transaction remains subject to due diligence, definitive agreements, regulatory approvals and Nasdaq listing requirements; no change to ABL S.A.’s control over ABL Diagnostics at this ...

Energy and marine consultancy ABL has secured new five-year contracts with long-term client Woodside Energy that expands its existing workscope outside of Australia. ABL has been awarded a global ...

Eli Lilly's $2.6 billion agreement with ABL Bio focuses on developing therapeutics using the Grabody Platform for bispecific antibodies. ABL Bio will receive an upfront payment and potential milestone ...

South Korea’s newest billionaire is Lee Sang-hoon, founder of Seoul-based ABL Bio, after it struck a $2.6 billion licensing and joint research deal with Eli Lilly for its bispecific antibody ...

Bispecific antibody specialist corporations ABL Bio said on the 14th that it signed an equity investment deal worth 22 billion won ($15 million) with U.S. pharmaceutical corporations Eli Lilly and ...

ABL Bio said on the 12th that it signed a technology transfer and joint research and development agreement with U.S.-based Eli Lilly for the "Grabody-B" platform, a technology that penetrates the ...

Behringer has announced the release of BQ-10, an analogue semi-modular sequencer based on the classic Korg SQ-10. Having first teased BQ-10 all the way back in 2023, Behringer has made the instrument ...

Abacus Global Management Inc (NASDAQ:ABL) reported a record quarter with a 124% year-over-year increase in total revenue, reaching $63 million. The company achieved its 10th consecutive quarter of ...

Neok Bio has exited stealth with $75 million to take a pair of bispecific antibody-drug conjugates sourced from ABL Bio into the clinic. ABL, a Korean biotech that is partnered with companies ...